Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. | 78,121 | reported | 03 Mar 2026 | tx 5+214,000−6,713 |
| Revance Therapeutics, Inc. | 20,883 | reported | 06 Feb 2025 | tx 63+867,373−335,419 |
| Achaogen Inc | 4,000 | reported | 26 Jun 2018 | tx 15+273,240−6,514 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2026 | SALE | Crinetics Pharmaceuticals, Inc. | 6,713 | 39.67 USD | |
| 23 Feb 2026 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 32,000 | 0.00 USD | |
| 23 Feb 2026 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 50,000 | 0.00 USD | deriv |
| 10 Mar 2025 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 52,000 | 0.00 USD | |
| 10 Mar 2025 | GRANT_AWARD | Crinetics Pharmaceuticals, Inc. | 80,000 | 0.00 USD | deriv |
| 06 Feb 2025 | OTHER | Revance Therapeutics, Inc. | 20,883 | — | |
| 04 Feb 2025 | TENDER | Revance Therapeutics, Inc. | 97,999 | 3.65 USD | |
| 06 Feb 2025 | OTHER | Revance Therapeutics, Inc. | 103,555 | — | |
| 06 Feb 2025 | GRANT_AWARD | Revance Therapeutics, Inc. | 20,883 | 0.00 USD | |
| 03 Feb 2025 | GRANT_AWARD | Revance Therapeutics, Inc. | 6,888 | 0.00 USD | |
| 31 Dec 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 1,000 | 2.18 USD | |
| 30 Jun 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 1,000 | 2.18 USD | |
| 18 Mar 2024 | SALE | Revance Therapeutics, Inc. | 9,361 | 5.04 USD | |
| 15 Mar 2024 | TAX_WITHHOLDING | Revance Therapeutics, Inc. | 3,822 | 5.31 USD | |
| 29 Feb 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 17,447 | 0.00 USD | |
| 31 Jan 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 96,667 | 0.00 USD | |
| 31 Jan 2024 | GRANT_AWARD | Revance Therapeutics, Inc. | 145,001 | 0.00 USD | deriv |
| 31 Dec 2023 | GRANT_AWARD | Revance Therapeutics, Inc. | 434 | 7.47 USD | |
| 11 Aug 2023 | TAX_WITHHOLDING | Revance Therapeutics, Inc. | 11,215 | 18.91 USD | |
| 11 Aug 2023 | GRANT_AWARD | Revance Therapeutics, Inc. | 22,620 | 0.00 USD | |
| 03 Jul 2023 | SALE | Revance Therapeutics, Inc. | 1,701 | 25.04 USD | |
| 30 Jun 2023 | GRANT_AWARD | Revance Therapeutics, Inc. | 769 | 15.61 USD | |
| 02 Jun 2023 | SALE | Revance Therapeutics, Inc. | 500 | 31.00 USD | |
| 01 Jun 2023 | SALE | Revance Therapeutics, Inc. | 2,701 | 30.57 USD | |
| 15 May 2023 | SALE | Revance Therapeutics, Inc. | 21,401 | 34.55 USD |